Cambridge Investment Research Advisors
LUNG icon

Cambridge Investment Research Advisors’s Pulmonx LUNG Stock Holding History

Cambridge Investment Research Advisors’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,447
Closed -$556K – 3233
2021
Q3 		$556K Buy
+15,447
New +$608K ﹤0.01% 1962

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cambridge Investment Research Advisors's LUNG Position: Q4 2021 in Review

Cambridge Investment Research Advisors sold out of Pulmonx (LUNG) in Q4 2021, closing a stake of 15,447 shares — an estimated $556K sold.

Cambridge Investment Research Advisors first reported a position in LUNG in Q3 2021 and held it in 1 quarter. The position peaked at $556K in Q3 2021. 114 funds tracked by Wall St. Rank hold LUNG as of Q4 2021.

  • Cambridge Investment Research Advisors reported no remaining Pulmonx position as of Q4 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 15,447 Pulmonx shares in Q4 2021, an estimated $556K.
  • Cambridge Investment Research Advisors first reported a position in Pulmonx in Q3 2021 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Pulmonx position peaked at $556K in Q3 2021.
  • 114 funds tracked by Wall St. Rank held Pulmonx as of Q4 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.